
1. plos one. 2011;6(10):e24586. doi: 10.1371/journal.pone.0024586. epub 2011 oct 7.

adenovirus 5-vectored p. falciparum vaccine expressing csp ama1. part a:
safety immunogenicity seronegative adults.

sedegah m(1), tamminga c, mcgrath s, house b, ganeshan h, lejano j, abot e,
banania gj, sayo r, farooq f, belmonte m, manohar n, richie no, wood c, long ca, 
regis d, williams ft, shi m, chuang i, spring m, epstein je, mendoza-silveiras j,
limbach k, patterson nb, bruder jt, doolan dl, king cr, soisson l, diggs c,
carucci d, dutta s, hollingdale mr, ockenhouse cf, richie tl.

author information: 
(1)u.s. military malaria vaccine program, naval medical research center, silver
spring, maryland, united states america. martha.sedegah@med.navy.mil

background: models immunity malaria indicate importance cd8+ cell 
responses targeting intrahepatic stages antibodies targeting
sporozoite blood stages. designed multistage adenovirus 5 (ad5)-vectored
plasmodium falciparum malaria vaccine, aiming induce types responses
in humans, tested safety immunogenicity phase 1 dose
escalation trial ad5-seronegative volunteers.
methodology/principal findings: nmrc-m3v-ad-pfca vaccine combines two
adenovectors encoding circumsporozoite protein (csp) apical membrane
antigen-1 (ama1). group 1 (n = 6) healthy volunteers received one intramuscular
injection 2×10∧10 particle units (1×10∧10 construct) group 2 (n = 6) 
a five-fold higher dose. transient, mild moderate adverse events more
pronounced higher dose. elispot responses csp ama1 peaked 1
month, higher low dose (geomean csp = 422, ama1 = 862 spot forming
cells/million) high dose (csp = 154, p = 0.049, ama1 = 423,
p = 0.045) group still positive 12 months number volunteers. 
elispot depletion assays identified dependence cd4+ cd4+ cd8+ t
cells, responses dependent cd8+ cells. intracellular cytokine 
staining detected stronger cd8+ cd4+ cell ifn-γ responses (csp p = 0.0001,
ama1 p = 0.003), similar frequencies multifunctional cd4+ cd8+ cells
secreting two ifn-γ, tnf-α il-2. median fluorescence intensities
were 7-10 fold higher triple single secreting cells. antibody responses
were low trended higher high dose group inhibit growth 
cultured p. falciparum blood stage parasites.
significance: found trials, adenovectored vaccines appeared safe 
well-tolerated doses 1×10∧11 particle units. first
demonstration humans malaria vaccine eliciting strong cd8+ cell ifn-γ
responses.
trial registration: clinicaltrials.govnct00392015.

doi: 10.1371/journal.pone.0024586 
pmcid: pmc3189181
pmid: 22003383  [indexed medline]

